Skip to content

13F-HR filed by Sands Capital Alternatives, LLC

Sands Capital Alternatives, LLC filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-13 18:08:07 UTC, with 24 holding rows worth $694,687,815.

Accession
0001846444-26-000013
Filed
2026-11-13
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 24 entries on the cover page, a total value of $694,687,815 stated on the cover page (in dollars after the unit check, H1), rows summing to $694,687,815 with VALUE read as dollars as filed, 13F file number 028-21032. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ALAMAR BIOSCIENCES INC010911105COMMON STOCK4,230,926$144,147,649dollars as filed
NU HLDGS LTDG6683N103ORD SHS CL A6,991,934$88,517,884dollars as filed
BETA BIONICS INC08659B102COMMON STOCK3,997,898$75,880,104dollars as filed
SPYGLASS PHARMA INC85220G109COMMON STOCK2,500,012$65,000,312dollars as filed
KLAVIYO INC COM SER A49845K101Stock3,827,359$60,204,357dollars as filed
10X GENOMICS INC CL A COM88025U109Stock481,770$43,532,737dollars as filed
INHIBIKASE THERAPEUTICS INC45719W205COMMON STOCK13,018,965$26,819,068dollars as filed
CEREBRAS SYSTEMS INC COM CL A15675D103Stock122,484$21,759,283dollars as filed
DOORDASH INC CL A25809K105Stock107,301$19,695,099dollars as filed
Odyssey Therapeutics, Inc.67613T104COMMON STOCK875,000$19,442,500dollars as filed
FREENOME INC35661P100COMMON STOCK1,201,998$18,931,469dollars as filed
COUPANG INC22266T109CL A1,244,409$17,259,953dollars as filed
DATADOGINCCLASSA23804L103STOK63,020$17,258,027dollars as filed
SAMSARA INC COM CL A79589L106Stock395,621$15,085,029dollars as filed
TOASTINCCLASSCLASSA888787108STOK314,907$9,129,154dollars as filed
ACUMEN PHARMACEUTICALS INC00509G209CMN3,720,105$8,258,633dollars as filed
SNOWFLAKE INC COM SHS833445109Stock22,926$7,784,753dollars as filed
TARSUS PHARMACEUTICALS INC87650L103COMMON STOCK85,000$6,681,850dollars as filed
SERVICETITAN INC SHS CL A81764X103Stock91,101$5,993,535dollars as filed
BIOAGE LABS INC COM09077V100Stock786,353$5,575,243dollars as filed
MONDAY COM LTD SHSM7S64H106Stock67,182$5,271,100dollars as filed
ACRIVON THERAPEUTICS INC004890109CMN2,289,271$4,693,006dollars as filed
CANDEL THERAPEUTICS INC137404109COMMON STOCK405,837$4,236,938dollars as filed
TAYSHA GENE THERAPIES INC877619106COMMON STOCK724,873$3,530,132dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001846444-26-000013this filing2026-11-13